Effect of dialysis on bleeding time in chronic renal failure

Journal of the Pakistan Medical Association

Volumn 48, Issue 8, 1998, Pages 242-244

  Butt, Mohammed Luqman ^a   Shafi, Tahir ^b   Farooqi, Iftekhar ^c   Moinuddin, ^a  

^a BOLAN MEDICAL COLLEGE   (Pakistan)

^b Sheikh Zayed Hospital   (Pakistan)

^c Baqai Medical College ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLEEDING TIME; CHRONIC KIDNEY FAILURE; FEMALE; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; RENAL REPLACEMENT THERAPY;

ADOLESCENT; ADULT; AGED; BLEEDING TIME; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 0032129750     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Eknoyan G, Wacksman SJ, Glueek HJ et al. Platelet dysfunction in renal failure. N. Engl. J. Med., 1969;280:677-81.
2. Janson PA, Jubelirer SJ, Weinstein MJ et al. Treatment of the bleeding tendency in uraemia with cryoprecipitate. N. Engl. J. Med., 1980;303:1318-22.
3. Smith MC and Dunn MJ. Impaired platelet thromboxane production in renal failure. Nephron, 1981;29:133-7.
4. Hougie C. Bleeding time. In: Williams, WJ, Beutler E, Erslev AJ, et al. Haematology. 3rd ed. Singapore, McGraw-Hill, 1986, p. 1671.
5. Lewis JH, Zucker MB, Ferguson JH. Bleeding tendency in uraemia. Blood, 1956;11:1073-76.
6. Nenci GG, Berrettini M, Agnelli G et al. Effect of peritoneal dialysis, hemodialysis, kidney transplantation on platelet function. Nephron, 1979;23:287-92.
7. Kazatchkine M, Sultan Y, Caen JP et al. Bleeding in renal failure: A possible cause. Br. Med. J., 1976;2612-5.
8. Remuzzi G, Cavenaghi AE, Mecca G et al. Prostacyclin like activity, bleeding in renal failure Lancet, 1977;2:1195-7.
9. Minno GD, Martinez J, Makean ML et al. Platelet dysfunction in uraemia, multifaceted defect partially corrected by dialysis. Am.J. Med., 1985;79:552-9.
10. Rabiner SF, Hodec J. Platelet factor-3 in normal subjects and patients with renal failure. J. Clin. Invest. 1968;47:901-12.
11. Tison P, Kubisz, P., Cernacek P. et al. Influence of inhibitor of glucose utilization on the platelet dysfunction. Nephron, 1983;33:253-6.
12. Horowitz HI, Stein IM, Cohen BD et al. Further studies on platelet-inhibitory effect of guanidino-succinic acid and its role in uraemic bleeding. Am. J. Med., 1970;49:336-45.
13. Rabiner SF. Bleeding abnormalities. In Massery SG, Sellers AI. Clinical aspects of uraemia and dialysis. Springfield, Charles, C. Thomas publisher, 1976, pp. 179-84.
14. Cheney K, Bonnin JA. Haemorrhage, platelet dysfunction and other coagulation defects in uremia. Br. J. Haematol., 1961;8:215-22.
15. Evans EP, Branch RA, Bloom AI. A clinical and experimental study of platelet function in chronic renal failure. J. Clin. Pathol., 1972;25:745-53.
16. Ivanovich P, Kwaan OG, Hathiwala S. Studies of coagulation and platelet function in heparin free hemodialysis. Nephron, 1983;33:116-20.
17. Mannucci PM, Remmuzi G, Pusineri F et al. Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia. N. Engl. J. Med., 1983;308:8-11.
18. Bloom A, Greaves M, Preston FE et al. Evidence against a platelet cyclooxygenase defect in uraemic subjects on chronic haemodialysis. Br. J. Haematol., 1986;62:143-9.
19. Hutton RA, Shea MJO. Homeostatic mechanism in uremia. J. Clin. Pathol., 1968;21:406-11.
20. Harker LA, Slighter SJ. The bleeding time as a screening test for evaluation of platelet function. N. Engl. J. Med., 1972;287:155-9.